The LRRK2 gene is mutated in a chinese autosomal-dominant Parkinson's disease family

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 2, 2013, Pages 131-134

  Guo, Rui ^a   Hu, Xinyu ^b   Chen, Qiuhui ^a   Zhang, Ying ^a   Zhang, Yizhi ^a   Sun, Yajuan ^a   Hu, Guohua ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GENOMIC DNA; GLYCINE;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD SAMPLING; CHINESE; CLINICAL ARTICLE; CODON; DNA ISOLATION; DNA SEQUENCE; FAMILY; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; HUMAN; LEUCINE RICH REPEAT KINASE2 GENE; MALE; MUTATIONAL ANALYSIS; PARKINSON DISEASE; PATHOGENESIS; PEDIGREE; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE ANALYSIS, DNA;

EID: 84872853285     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0294     Document Type: Article

References (18)

1. Di Fonzo A, et al. (2006) A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 7:133-138.
2. Farrer M, Ross OA (1993) LRRK2-related parkinson disease. In: Pagon RA, et al. (eds) GeneReviews. University of Washington, Seattle, WA. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1208.
3. Farrer MJ, et al. (2007) Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 13:89-92.
4. Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40:617-647.
5. Hughes AJ, et al. (1992) Accuracy of clinical diagnosis of idio-pathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184.
6. Lesage S, et al. (2006) LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354:422-423.
7. Lin CH, et al. (2008) LRRK2 mutation in familial Parkinson's disease in a Taiwanese population: clinical, PET, and functional studies. J Biomed Sci 15:661-667.
8. Lu CS, et al. (2008) The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population. Neurogenetics 9:271-276.
9. Mata IF, et al. (2005) Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 6:171-177.
10. Peeraully T, Tan EK (2012) Genetic variants in sporadic Parkinson's disease: East vs West. Parkinsonism Relat Disord 18 Suppl 1:S63-S65.
11. Ross OA, Farrer MJ (2005) Pathophysiology, pleiotrophy and paradigm shifts: genetic lessons from Parkinson's disease. Biochem Soc Trans 33(Pt 4):586-590.
12. Ross OA, et al. (2011) Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 10:898-908.
13. Rudenko IN, et al. (2012) The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation. Biochem J 446:99-111.
14. Seki N, et al. (2011) Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease. J Hum Genet 56:671-675.
15. State Council of the People's Republic of China (2007) Administrative Regulations on Medical Institution, People's Republic of China.
16. Tan EK (2007) The role of common genetic risk variants in Parkinson disease. Clin Genet 72:387-393.
17. Wang C, et al. (2012) Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Par-kinsonism Relat Disord 18:958-963.
18. Zhou Y, et al. (2012) Association of Parkinson's disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population. J Clin Neurosci 19:1011-1015.